v3.23.2
SCHEDULE OF WARRANT OUTSTANDING AND EXERCISABLE WARRANTS (Details) - USD ($)
 6 Months Ended 12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants Outstanding, Number of Warrants  
Warrants Outstanding, Weighted Average Exercise Price Per Share $ 0.29 $ 1.14 $ 0.42 $ 2.00 $ 2.00
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) 4 years 1 month 6 days 2 years 10 months 24 days 3 years 8 months 12 days 3 years 10 months 24 days  
Warrants Outstanding, Aggregate Intrinsic Value     $ 107,014    
Warrants Outstanding, Number of Warrants 1,342,030 [1] 536,030 [1] 542,030 [1],[2] 272,000 [1],[2] 272,000 [2]
Warrant One [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants Outstanding, Number of Warrants     492,030    
Warrants Outstanding, Weighted Average Exercise Price Per Share $ 0.20   $ 0.26    
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) 4 years 10 months 24 days   4 years 3 months 18 days    
Warrants Outstanding, Aggregate Intrinsic Value   $ 107,014    
Warrants Exercisable, Number of Warrants 800,000   492,030    
Warrants Exercisable, Weighted Average Exercise Price Per Share $ 0.20   $ 0.26    
Warrants Exercisable, Weighted Average Remaining Contractual Life (Years) 4 years 10 months 24 days   4 years 3 months 18 days    
Warrants Exercisable, Aggregate Intrinsic Value   $ 107,014    
Warrants Outstanding, Number of Warrants 800,000        
Warrant Two [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants Outstanding, Number of Warrants     50,000    
Warrants Outstanding, Weighted Average Exercise Price Per Share $ 0.26   $ 2.00    
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) 3 years 9 months 18 days   1 year 9 months 18 days    
Warrants Outstanding, Aggregate Intrinsic Value        
Warrants Exercisable, Number of Warrants 492,030   50,000    
Warrants Exercisable, Weighted Average Exercise Price Per Share $ 0.26   $ 2.07    
Warrants Exercisable, Weighted Average Remaining Contractual Life (Years) 4 years 1 month 6 days   1 year 9 months 18 days    
Warrants Exercisable, Aggregate Intrinsic Value        
Warrants Outstanding, Number of Warrants 492,030        
Warrant [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants Outstanding, Number of Warrants     542,030    
Warrants Outstanding, Weighted Average Exercise Price Per Share $ 0.29   $ 1.14    
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) 4 years 4 months 24 days   4 years 1 month 6 days    
Warrants Outstanding, Aggregate Intrinsic Value   $ 107,014    
Warrants Exercisable, Number of Warrants 1,342,030   542,030    
Warrants Exercisable, Weighted Average Exercise Price Per Share $ 0.29   $ 0.42    
Warrants Exercisable, Weighted Average Remaining Contractual Life (Years) 4 years 4 months 24 days   4 years 1 month 6 days    
Warrants Exercisable, Aggregate Intrinsic Value   $ 107,014    
Warrants Outstanding, Number of Warrants 1,342,030        
Warrant Three [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Warrants Outstanding, Weighted Average Exercise Price Per Share $ 2.00        
Warrants Outstanding, Weighted Average Remaining Contractual Life (Years) 1 year 3 months 18 days        
Warrants Outstanding, Aggregate Intrinsic Value        
Warrants Exercisable, Number of Warrants 50,000        
Warrants Exercisable, Weighted Average Exercise Price Per Share $ 2.00        
Warrants Exercisable, Weighted Average Remaining Contractual Life (Years) 1 year 3 months 18 days        
Warrants Exercisable, Aggregate Intrinsic Value        
Warrants Outstanding, Number of Warrants 50,000        
[1] The warrant agreements issued in 2019 for a total of 50,000 warrants include provisions for dilutive issuance and cash-less exercise. If exercised at December 31, 2022 the provisions would have resulted in an issuance of 1,130,114 shares at an average conversion price of $0.09, or 1,050,114 shares in a cash-less exercise. In order to mitigate the Company’s risk an administrative hold has been placed on one shareholder’s stock in the event of future exercise.
[2] The warrant agreements issued in 2019 for a total of 50,000 warrants include provisions for dilutive issuance and cash-less exercise. If exercised at December 31, 2022 the provisions would have resulted in an issuance of